|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/22/20 AMERI Holdings, Inc. S-4/A 123:18M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: S-4/A Pre-Effective Amendment to Registration Statement HTML 5.53M
- Securities for a Merger
2: EX-5.1 Opinion of Counsel re: Legality HTML 36K
3: EX-8.1 Opinion of Counsel re: Tax Matters HTML 42K
4: EX-8.2 Opinion of Counsel re: Tax Matters HTML 37K
5: EX-8.3 Opinion of Counsel re: Tax Matters HTML 38K
6: EX-23.4 Consent of Expert or Counsel HTML 31K
7: EX-23.5 Consent of Expert or Counsel HTML 31K
14: R1 Document and Entity Information HTML 45K
15: R2 Condensed Consolidated Balance Sheets HTML 143K
16: R3 Condensed Consolidated Balance Sheets HTML 49K
(Parenthetical)
17: R4 Condensed Consolidated Statements of Operations HTML 144K
and Comprehensive Income (Loss)
18: R5 Condensed Consolidated Statements of Changes in HTML 116K
Stockholders' Equity
19: R6 Condensed Consolidated Statements of Cash Flows HTML 114K
20: R7 Description of Business HTML 45K
21: R8 Summary of Significant Accounting Policies HTML 93K
22: R9 Basis of Presentation HTML 51K
23: R10 Equity Transactions HTML 52K
24: R11 Business Combinations HTML 90K
25: R12 Revenue Recognition HTML 57K
26: R13 Intangible Assets HTML 47K
27: R14 Goodwill HTML 39K
28: R15 Share-Based Compensation HTML 36K
29: R16 Equity Compensation Plans HTML 72K
30: R17 Earnings (Loss) Per Share HTML 55K
31: R18 Debt HTML 44K
32: R19 Accrued Expenses and Other Current Liabilities HTML 37K
33: R20 Incentive Plan Items HTML 33K
34: R21 Employee Benefit Plan HTML 33K
35: R22 Income Taxes HTML 46K
36: R23 Bank Debt HTML 36K
37: R24 Convertible Notes HTML 37K
38: R25 Leases HTML 64K
39: R26 Fair Value Measurement HTML 55K
40: R27 Warrants Outstanding HTML 48K
41: R28 Preferred Stock HTML 34K
42: R29 Secured Note HTML 34K
43: R30 Loan From Paycheck Protection Program (Ppp) HTML 34K
44: R31 Loan From U.S. Small Business Administration HTML 34K
(Eidl)
45: R32 Exchange of Convertible Note and Promissory Notes HTML 34K
46: R33 Registered Direct Offering HTML 35K
47: R34 Material Agreements HTML 37K
48: R35 Revision of Prior Year Financial Statements HTML 104K
49: R36 Subsequent Events HTML 63K
50: R37 Summary of Significant Accounting Policies HTML 147K
(Policies)
51: R38 Summary of Significant Accounting Policies HTML 44K
(Tables)
52: R39 Business Combinations (Tables) HTML 63K
53: R40 Intangible Assets (Tables) HTML 47K
54: R41 Goodwill (Tables) HTML 37K
55: R42 Equity Compensation Plans (Tables) HTML 72K
56: R43 Revenue Recognition (Tables) HTML 44K
57: R44 Earnings (Loss) Per Share (Tables) HTML 51K
58: R45 Debt (Tables) HTML 37K
59: R46 Accrued Expenses and Other Current Liabilities HTML 37K
(Tables)
60: R47 Income Taxes (Tables) HTML 40K
61: R48 Leases (Tables) HTML 61K
62: R49 Fair Value Measurement (Tables) HTML 49K
63: R50 Warrants Outstanding (Tables) HTML 48K
64: R51 Revision of Prior Year Financial Statements HTML 101K
(Tables)
65: R52 Description of Business (Details Narrative) HTML 57K
66: R53 Description of Business (Details Narrative) (10-K) HTML 58K
67: R54 Summary of Significant Accounting Policies HTML 45K
(Details Narrative) (10-K)
68: R55 Summary of Significant Accounting Policies - HTML 52K
Schedule of Disaggregation of Revenue (Details)
(10-K)
69: R56 Equity Transactions (Details Narrative) (10-K) HTML 122K
70: R57 Business Combinations (Details Narrative) HTML 72K
71: R58 Business Combinations (Details Narrative) (10-K) HTML 120K
72: R59 Business Combinations - Summary of Foregoing HTML 85K
Acquisitions (Details)
73: R60 Revenue Recognition (Details Narrative) HTML 43K
74: R61 Revenue Recognition - Schedule of Disaggregate HTML 51K
Revenue (Details)
75: R62 Intangible Assets (Details Narrative) HTML 34K
76: R63 Intangible Assets (Details Narrative) (10-K) HTML 39K
77: R64 Intangible Assets - Schedule of Components of HTML 41K
Intangible Assets (Details) (10-K)
78: R65 Intangible Assets - Schedule of Future HTML 41K
Amortization of Intangible Assets (Details) (10-K)
79: R66 Goodwill (Details Narrative) HTML 34K
80: R67 Goodwill (Details Narrative) (10-K) HTML 34K
81: R68 Goodwill - Schedule of Goodwill (Details) (10-K) HTML 37K
82: R69 Share-Based Compensation (Details Narrative) HTML 39K
(10-K)
83: R70 Equity Compensation Plans (Details Narrative) HTML 40K
(10-K)
84: R71 Equity Compensation Plans - Schedule of Option HTML 74K
Activity (Details) (10-K)
85: R72 Earnings (Loss) Per Share - Schedule of Earnings HTML 65K
Per Share Basic and Diluted (Details)
86: R73 Earnings / (loss) Per Share - Schedule of Earnings HTML 68K
Per Share Basic and Diluted (Details) (10-K)
87: R74 Debt (Details Narrative) (10-K) HTML 78K
88: R75 Debt - Schedule of Short Term Debt (Details) HTML 39K
(10-K)
89: R76 Accrued Expenses and Other Current Liabilities - HTML 46K
Schedule of Accrued Expenses and Other Liabilities
(Details) (10-K)
90: R77 Incentive Plan Items (Details Narrative) HTML 33K
91: R78 Employee Benefit Plan (Details Narrative) (10-K) HTML 39K
92: R79 Income Taxes (Details Narrative) (10-K) HTML 38K
93: R80 Income Taxes - Schedule of Provision for Income HTML 55K
Tax (Details) (10-K)
94: R81 Bank Debt (Details Narrative) HTML 47K
95: R82 Convertible Notes (Details Narrative) HTML 68K
96: R83 Leases (Details Narrative) HTML 36K
97: R84 Leases (Details Narrative) (10-K) HTML 36K
98: R85 Leases - Schedule of Components of Lease Expense HTML 37K
(Details)
99: R86 Leases - Schedule of Components of Lease Expense HTML 37K
(Details) (10-K)
100: R87 Leases - Schedule of Supplemental Balance Sheet HTML 40K
Information Related to Leases (Details)
101: R88 Leases - Schedule of Supplemental Balance Sheet HTML 40K
Information Related to Leases (Details) (10-K)
102: R89 Leases - Schedule of Supplemental Cash Flow and HTML 41K
Other Information Related to Leases (Details)
103: R90 Leases - Schedule of Supplemental Cash Flow and HTML 41K
Other Information Related to Leases (Details)
(10-K)
104: R91 Leases - Schedule of Maturity Payments of HTML 51K
Operating Leases (Details)
105: R92 Leases - Schedule of Maturity Payments of HTML 47K
Operating Leases (Details) (10-K)
106: R93 Fair Value Measurement - Schedule of Financial HTML 42K
Assets Measured at Fair Value (Details) (10-K)
107: R94 Fair Value Measurement - Schedule of Fair Value HTML 41K
Change in Levels (Details) (10-K)
108: R95 Warrants Outstanding - Schedule of Warrant HTML 50K
Outstanding (Details)
109: R96 Warrants - Schedule of Warrants Activity (Details) HTML 55K
(10-K)
110: R97 Preferred Stock (Details Narrative) HTML 43K
111: R98 Secured Note (Details Narrative) HTML 37K
112: R99 Loan From Paycheck Protection Program (Ppp) HTML 42K
(Details Narrative)
113: R100 Loan From U.S. Small Business Administration HTML 43K
(Eidl) (Details Narrative)
114: R101 Exchange of Convertible Note and Promissory Notes HTML 41K
(Details Narrative)
115: R102 Registered Direct Offering (Details Narrative) HTML 51K
116: R103 Material Agreements (Details Narrative) HTML 47K
117: R104 Revision of Prior Year Financial Statements - HTML 143K
Schedule of Consolidated Financial Statements
Previously (Details)
118: R105 Revision of Prior Year Financial Statements - HTML 143K
Schedule of Consolidated Financial Statements
Previously (Details) (10-K)
119: R106 Subsequent Events (Details Narrative) HTML 51K
120: R107 Subsequent Events (Details Narrative) (10-K) HTML 70K
122: XML IDEA XML File -- Filing Summary XML 229K
121: EXCEL IDEA Workbook of Financial Reports XLSX 166K
8: EX-101.INS XBRL Instance -- amrh-20200630 XML 2.39M
10: EX-101.CAL XBRL Calculations -- amrh-20200630_cal XML 248K
11: EX-101.DEF XBRL Definitions -- amrh-20200630_def XML 808K
12: EX-101.LAB XBRL Labels -- amrh-20200630_lab XML 1.27M
13: EX-101.PRE XBRL Presentations -- amrh-20200630_pre XML 1.15M
9: EX-101.SCH XBRL Schema -- amrh-20200630 XSD 266K
123: ZIP XBRL Zipped Folder -- 0001493152-20-019817-xbrl Zip 221K
Exhibit 23.5
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of AMERI Holdings, Inc. on Amendment No. 2 to Form S-4 [File No. 333-238742] of our report dated April 21, 2020, which report includes an explanatory paragraph relating to substantial doubt about the ability of Jay Pharma, Inc. to continue as a going concern, with respect to our audits of the financial statements of Jay Pharma, Inc. as of December 31, 2019 and 2018 and for each of the two years in the period ended December 31, 2019, which report appears in the joint proxy statement/prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such joint proxy statement/prospectus.
/s/ Marcum llp
Marcum llp
New York, NY
October 20, 2020
C:
| This ‘S-4/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/22/20 | CORRESP | ||
| 4/21/20 | ||||
| 12/31/19 | 10-K, 10-K/A | |||
| 12/31/18 | 10-K, 10-K/A | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/10/20 Enveric Biosciences, Inc. S-4/A 121:18M M2 Compliance LLC/FA 11/09/20 Enveric Biosciences, Inc. S-4/A 122:18M M2 Compliance LLC/FA |